share_log

科伦药业(002422.SZ):公司盐酸达泊西汀2023年销售收入0.34亿元

Sichuan Kelun Pharmaceutical (002422.SZ): The sales revenue of 0.034 billion yuan for the company's Dapoxetine hydrochloride in 2023.

Gelonghui Finance ·  Jul 11 04:08

On July 11th, Gelunhui reported that Sichuan Kelun Pharmaceutical (002422.SZ) stated on the investor interaction platform that the sales revenue of dapoxetine hydrochloride will be 0.034 billion yuan in 2023.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment